Different Levels of Blood Flow Restriction Versus Moderate Intensity Exercises in Patients With Knee Osteoarthritis

May 2, 2026 updated by: Farah Fouad Gomaa El Gamal, Cairo University

Blood Flow Restriction With Different Loads Versus Moderate Resistive Exercises in Patients With Knee Osteoarthritis: A Double Blinded Randomized Controlled Trial

This clinical trail will be conducted to investigate the effect of blood flow restriction (BFR) with different load levels between low blood occlusion percentage (50%) group and high blood occlusion percentage (70%) compared to moderate intensity training (60% of 1 RM) in patients with chronic knee osteoarthritis.

The main questions it aims to answer are:

  1. Will there be no difference between the effect of (70% vs 50%) of BFR versus traditional moderate resistive training exercises on pain intensity in knee osteoarthritis ?
  2. Will there be no difference between the effect of (70% vs 50%) of BFR versus traditional moderate resistive training exercises on quadriceps muscle strength in knee osteoarthritis ?
  3. Will there be no difference difference between the effect of (70% vs 50%) of BFR versus traditional moderate resistive training exercises on rate of perceived exertion in knee osteoarthritis ?
  4. Will there be no difference between the effect of (70% vs 50%) of BFR versus traditional moderate resistive training exercises on functional ability in knee osteoarthritis ?
  5. Will there be no difference between the effect of (70% vs 50%) of BFR versus traditional moderate resistive training exercises on physical function in knee osteoarthritis ?

All participants will receive:

  1. 16 sessions of supervised intervention 2 times per week for 8 weeks.
  2. The assessment will be at 3 time points, baseline and at 4 weeks and at 8 weeks.

Study Overview

Detailed Description

Knee osteoarthritis (KOA) is a prevalent degenerative musculoskeletal condition that primarily causing pain, stiffness, and disability. It is a multifactorial disease influenced by a combination of genetic, biomechanical, and environmental factors Osteoarthritis Research Society International (ORSI) recommended strength training as a possible treatment method to slow progression of knee OA. Strength training, as recommended by the American College of Sports Medicine (ACSM), must be performed at a minimum resistance training load of 60% to 70% 1-repetition maximum (1RM) for strength improvement.

Only 13% of older patients with knee OA satisfactorily can perform moderate to vigorous physical activity.

Unfortunately, risk factors of knee OA (as obesity, knee pain, knee injury/surgery) also contribute to a perceived reduced tolerance to the resistive training programs recommended for eliciting strength gains.

An alternative to traditional strength training that may be well tolerated by patients with Knee OA is Blood flow restriction (BFR) training.

This reduced blood flow creates a unique physiological environment, inducing a state of metabolic stress and cellular hypoxia in the muscles.

Although the advantages of BFRT in musculoskeletal rehabilitation that reported in the literature, there are conflicting results compared to traditional exercises, as the different protocols parameters, exercises, high risk of bias across previous studies contribute to different conclusions.

Consequently, it raises the question if BFR without exercises can be effective in comparison with traditional exercises that focus on having an efficient intensity to produce muscle strength gain.

Yet, up to authors knowledge, no study has assessed whether BFR at rest could also promote similar gains in muscle strength for the knee OA treatment, which theoretically would increase patient's adherence to KOA treatment based on conclusions of systemic review of BFR without exercises for immobilized patients after orthopedic surgery (Cerqueira et al., 2019).

Another relevant issue is the proper blood flow restriction level for optimal results. Thus, pushes the need for determining a pressure load with the least adverse effects.

Therefore, the main purpose of this study is to assess different protocols of BFR without additional exercises compared to MI-RT for pain reduction in patients with KOA. The secondary purpose is to compare two load levels (70% vs 50%) of BFRT regarding pain, quadriceps muscle strength, rate of perceived exertion, self reported physical function, and functional ability.

Study Type

Interventional

Enrollment (Estimated)

75

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Giza Governorate
      • Cairo, Giza Governorate, Egypt, 12611
        • CairoU

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Patients diagnosed with chronic knee osteoarthritis referred by orthopedic surgeons participants of both genders age are 40-65.
  • Patients with grade 2 and 3 OA of the knee, according to radiologic evaluation
  • If both knees diagnosed as OA, the most affected one will be selected.
  • Diagnosis of Knee OA who had knee pain and functional disabilities for at least three months, according to American College of Rheumatology classification at screening visit.
  • Visual Analogue Scale (VAS) at rest score of ≥40 mm.
  • Arabic version of the western WOMAC (ArWOMAC) scores (average 37).
  • Moderate Physical activity score on the IPAQ (between 3.0 and 7.9 METS).

Exclusion Criteria:

  • Moderate to significant knee synovitis
  • Hot or red knee
  • History and/or physical examination findings compatible with the internal derangement of knee.
  • Knee pain that is initiated or increased with knee activity/exercise and finished or decreased with knee resting.
  • Other muscular, articular, or neurological condition affecting lower limb function.
  • Patients with any previous knee surgeries or fractures of lower limb
  • Patients who had undergone arthroscopy or treatment with intra-articular hyaluronic acid during the previous 6 months.
  • Psychological or psychiatric disorders that may affect a subject's participation in the study.
  • Participants with congenital musculoskeletal lower limb deformity.
  • Participated in other intervention studies on the past 6 months to screening
  • Participants with contraindications to blood flow Restriction Training.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Non-Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: 50% Blood Flow Restriction Group

The Blood Flow Restriction device will be set to restrict blood flow at level of 50% of arterial occlusion pressure at rest.

Blood Flow Restriction sessions will be 5 sets of 5 mins of occlusion and 3 mins of free flow , 2 sessions per week for eight weeks exercises to assess its effects on knee osteoarthritis-related outcomes.

Blood Flow Restriction (BFR) therapy involves units use standardized cuffs of varying widths and lengths which are physically attached to the devices and provide the capability of precisely controlling the amount of pressure applied to each limb during exercise or at rest.

We will be using Smart Cuffs® 4.0 which allows for a fast, hassle-free personalized pressure calculation. With the built-in pressure sensor and on-board computer, it will calculate and set the optimal pressure for each participant's limb. There is no need for an external doppler probe or hand pump. Made in the USA, SmartCuffs® are registered with the FDA as a Class 1 Medical Device.

Blood flow restriction therapy is commonly paired with resistive training, so this study will explore the effect of blood flow restriction at rest for patients with osteoarthritis at different restriction levels (50% for first group and 70% for second group).

Other Names:
  • Smart cuffs 4.0
Experimental: 70% Blood Flow Restriction Group

The Blood Flow Restriction device will be set to restrict blood flow at level of 70% of arterial occlusion pressure at rest.

Blood Flow Restriction sessions will be 5 sets of 5 mins of occlusion and 3 mins of free flow , 2 sessions per week for eight weeks exercises to assess its effects on knee osteoarthritis-related outcomes.

Blood Flow Restriction (BFR) therapy involves units use standardized cuffs of varying widths and lengths which are physically attached to the devices and provide the capability of precisely controlling the amount of pressure applied to each limb during exercise or at rest.

We will be using Smart Cuffs® 4.0 which allows for a fast, hassle-free personalized pressure calculation. With the built-in pressure sensor and on-board computer, it will calculate and set the optimal pressure for each participant's limb. There is no need for an external doppler probe or hand pump. Made in the USA, SmartCuffs® are registered with the FDA as a Class 1 Medical Device.

Blood flow restriction therapy is commonly paired with resistive training, so this study will explore the effect of blood flow restriction at rest for patients with osteoarthritis at different restriction levels (50% for first group and 70% for second group).

Other Names:
  • Smart cuffs 4.0
Active Comparator: Moderate Intensity Exercise training Group

Patients assigned to this group will receive strengthening of the lower limb musculature through moderate intensity resistance training (60% of 1RM) for a total of 16 treatment sessions according to exercise guidelines for seniors with OA.

MIRT protocols consists of 3 sets for every exercise, 12 repetitions per set, rest period between sets 2 mins, 2 session per week for 8 weeks.

Resistance exercises will be performed using a 45° leg-press machine, 90°-0° of knee flexion knee extension machine, leg curl machine and calf raise machine.

Patients assigned to group will receive strengthening of the lower limb musculature through moderate intensity resistance training (60% of 1RM) using a 45° leg-press machine, 90°-0° of knee flexion knee extension machine, leg curl machine and calf raise machine.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in pain intensity
Time Frame: Measured 3 times at basline, 4 weeks and 8 weeks

Measured by the Visual Analog Scale (VAS)which is a pain intensity assessment tool.

  • Represented with a 10 cm line with 0 indicating no pain and on the other end 10 indicating severe pain.
  • The patient is asked to move a marker on the line to the position which best describes their pain.
  • That it will serve as a subjective measure of their current level of knee pain intensity.

The closer the mark to zero is better.

Measured 3 times at basline, 4 weeks and 8 weeks
Measure change in quadriceps muscle strength
Time Frame: Measured 3 times at baseline, 4 weeks and 8 weeks

Hand-held dynamometer (HHD) will be used to measure the strength in quadriceps muscle.

  • The maximum force or pressure exerted by the quadriceps muscle during the contraction will be recorded.
  • Typically, this measurement is expressed in kilograms (kg) and then transferred to Newtons (N)
  • To enhance reliability, 3 trials may be conducted, and average will be taken to obtain a more representative measurement of muscle strength.
  • The higher the measurement the higher the muscle strength.
Measured 3 times at baseline, 4 weeks and 8 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in functional ability
Time Frame: Measured 3 times at baseline, 4 weeks and 8 weeks

Measured by Timed Up and Go Test (TUG) to assess participants' mobility, balance, and functional performance.

  • The time taken by the patient to complete the entire sequence from rising from the chair to returning to a seated position will be measured.
  • This time will be recorded in seconds, representing the TUG test score.
  • 3 times will be conducted to ensure the accuracy of the TUG test score.
  • The average time from these trials will be calculated for a more reliable result.
  • High Risk of fall (>13.5 seconds)
  • None/low/moderate (<13.5 seconds) The lower the number the better as it represents better mobility, balance and functional performance.
Measured 3 times at baseline, 4 weeks and 8 weeks
Change in physical function levels
Time Frame: Measured 3 times at baseline, 4 weeks and 8 weeks

Measured by Arabic version of Western Ontario McMaster Universities Osteoarthritis Index for Knee Function (ArWOMAC).

The WOMAC questionnaire will be handed out to the participants. They will be informed that it consists of a series of questions related to their knee symptoms and how these symptoms affect their daily activities.

WOMAC is assigned a numerical score of 0-4 corresponding to severity (none, mild, moderate, severe, and extreme). The minimum score is 0, and the maximum score is 96 (20 points for pain, 8 points for joint stiffness, and 68 points for physical function).

The lower the score the better.

Measured 3 times at baseline, 4 weeks and 8 weeks
Change in Rate of perceived exertion scale (RPE)
Time Frame: Measured 3 times at basline , 4 weeks and 8 weeks

Measured by Arabic version of Omnibus Resistance Exercise 0-10 (OMNI-RES) as a scale for measuring an individual's effort and exertion, breathlessness and fatigue during physical work.

  • The OMNI Picture System is a collection of category scales used for rating of perceived exertion (RPE) as the subjective intensity of a person's feelings of effort, strain, discomfort, and/or fatigue when engaged in exercise or other physical activities.
  • With OMNI exertion scales, users select a number from 0 to 10 that best corresponds to their perceived intensity of physical exertion.
  • 0 represents extremely easy and 10 represents extremely hard.
  • The lower the number the better.
Measured 3 times at basline , 4 weeks and 8 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Lecturer, Cairo University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 15, 2024

Primary Completion (Actual)

February 26, 2025

Study Completion (Estimated)

May 6, 2026

Study Registration Dates

First Submitted

September 24, 2024

First Submitted That Met QC Criteria

October 9, 2024

First Posted (Actual)

October 15, 2024

Study Record Updates

Last Update Posted (Actual)

May 6, 2026

Last Update Submitted That Met QC Criteria

May 2, 2026

Last Verified

September 1, 2025

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

  • The risk that sharing prevents the exploitation of the entire potential of the data obtained.
  • Possible failures in patients' privacy protection.
  • Technical barriers such as the lack of standard formats and possible data misinterpretation.
  • Issues regarding data ownership.
  • Reuse of data for unfair commercial purposes.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

Yes

product manufactured in and exported from the U.S.

Yes

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Knee Osteoarthritis

Clinical Trials on Blood Flow Restriction Therapy Device

Subscribe